The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease
- PMID: 37511095
- PMCID: PMC10378918
- DOI: 10.3390/ijms241411336
The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease
Abstract
Psoriasis is a complex chronic immunologically mediated disease that may involve skin, nails, and joints. It is characterized by hyperproliferation, deregulated differentiation, and impaired apoptosis of keratinocytes. Sphingolipids, namely ceramide, sphingosine-1-phosphate, sphingosine, sphingomyelin, and sphinganine-1-phosphate, are signal molecules that may regulate cell growth, immune reactions, and apoptosis. Fifteen patients with psoriasis and seventeen healthy persons were enrolled in the study. Skin samples were taken from psoriatic lesions and non-lesional areas. Tissue concentration of ceramides, sphingosine-1-phosphate, sphingosine, sphingomyelin, and sphinganine-1-phosphate was measured by liquid chromatography. We assessed that all levels of ceramides, sphingosine-1-phosphate, sphingosine, sphingomyelin, and sphinganine-1-phosphate were higher in lesioned psoriatic skin than in non-affected skin. The profile of bioactive lipids in the lesional skin of patients with psoriasis differed significantly from non-involved psoriatic skin and skin in healthy subjects.
Keywords: ceramide; psoriasis; sphinganine; sphinganine-1-phosphate; sphingosine; sphingosine-1-phosphate.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Crosstalk between Serum and Skin Sphingolipids in Psoriasis.Int J Mol Sci. 2023 Oct 3;24(19):14872. doi: 10.3390/ijms241914872. Int J Mol Sci. 2023. PMID: 37834321 Free PMC article.
-
Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.Arch Dermatol Res. 2017 Mar;309(2):79-86. doi: 10.1007/s00403-016-1709-9. Epub 2016 Dec 17. Arch Dermatol Res. 2017. PMID: 27988894 Free PMC article.
-
Altered levels of sphingosine and sphinganine in psoriatic epidermis.Ann Dermatol. 2013 Aug;25(3):321-6. doi: 10.5021/ad.2013.25.3.321. Epub 2013 Aug 13. Ann Dermatol. 2013. PMID: 24003275 Free PMC article.
-
The Role of Sphingolipids in the Pathogenesis of Psoriasis.Metabolites. 2022 Nov 24;12(12):1171. doi: 10.3390/metabo12121171. Metabolites. 2022. PMID: 36557209 Free PMC article. Review.
-
Emerging Roles of Ceramides in Breast Cancer Biology and Therapy.Int J Mol Sci. 2022 Sep 23;23(19):11178. doi: 10.3390/ijms231911178. Int J Mol Sci. 2022. PMID: 36232480 Free PMC article. Review.
Cited by
-
Altered metabolic profiles of dermatomyositis with different myositis-specific autoantibodies associated with clinical phenotype.Front Immunol. 2024 Nov 25;15:1429010. doi: 10.3389/fimmu.2024.1429010. eCollection 2024. Front Immunol. 2024. PMID: 39654882 Free PMC article.
-
Crosstalk between Serum and Skin Sphingolipids in Psoriasis.Int J Mol Sci. 2023 Oct 3;24(19):14872. doi: 10.3390/ijms241914872. Int J Mol Sci. 2023. PMID: 37834321 Free PMC article.
-
Noninvasive markers for warning premature ovarian insufficiency: a Mendelian randomisation study.J Ovarian Res. 2025 Jun 10;18(1):127. doi: 10.1186/s13048-025-01696-1. J Ovarian Res. 2025. PMID: 40495196 Free PMC article.
-
Inhibition of Sphingosine-1-Phosphate Receptor 2 (S1P2) Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.Biomol Ther (Seoul). 2025 May 1;33(3):544-553. doi: 10.4062/biomolther.2024.197. Epub 2025 Apr 23. Biomol Ther (Seoul). 2025. PMID: 40262931 Free PMC article.
-
The Role of Sphingolipids and Sphingosine-1-phosphate-Sphingosine-1-phosphate-receptor Signaling in Psoriasis.Cells. 2023 Sep 26;12(19):2352. doi: 10.3390/cells12192352. Cells. 2023. PMID: 37830566 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical